malondialdehyde has been researched along with dihydrotestosterone in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Honda, M; Kinoshita, Y; Oikawa, R; Saito, M; Sejima, T; Shimizu, S; Tomita, S; Tsounapi, P | 1 |
Eskandari, E; Hedayati, M; Jafari, M; Khalagie, K; Mofid, M; Naghii, MR | 1 |
Jeon, WY; Lee, MY; Park, E; Seo, CS; Shin, HK; You, S | 1 |
Campolo, M; Cordaro, M; Cuzzocrea, S; Esposito, E; Filippone, A; Paterniti, I; Siracusa, R | 1 |
Refaie, MMM; Rifaai, RA; Zenhom, NM | 1 |
Chen, CW; Hsieh, RH; Lin, YL; Tsai, HH; Yu, PL | 1 |
Liu, J; Peng, X; Yu, J | 1 |
Billig, H; Brännström, M; Hu, M; Li, J; Liang, M; Ma, H; Ma, S; Sferruzzi-Perri, AN; Shao, LR; Wang, X; Wu, X; Zhang, Y | 1 |
8 other study(ies) available for malondialdehyde and dihydrotestosterone
Article | Year |
---|---|
Prostatic ischemia induces ventral prostatic hyperplasia in the SHR; possible mechanism of development of BPH.
Topics: Actins; Animals; Biomarkers; Blood Pressure; Dihydrotestosterone; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factor 2; Hypertension; Hypoxia-Inducible Factor 1, alpha Subunit; Ischemia; Male; Malondialdehyde; Oxidative Stress; Prostate; Prostatic Hyperplasia; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Regional Blood Flow; Transforming Growth Factor beta1 | 2014 |
The efficacy of antioxidant therapy against oxidative stress and androgen rise in ethylene glycol induced nephrolithiasis in Wistar rats.
Topics: Animals; Antioxidants; Ascorbic Acid; Boron; Dihydrotestosterone; Ethylene Glycol; Kidney; Malondialdehyde; Nephrolithiasis; Oxidative Stress; Rats, Wistar; Selenium; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome; Vitamin A; Vitamin B 6; Vitamin E; Vitamins; Zinc | 2015 |
Paljung-San, a traditional herbal medicine, attenuates benign prostatic hyperplasia in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cell Proliferation; Cell Survival; Cyclin D1; Cyclooxygenase 2; Dihydrotestosterone; Dinoprostone; Glutathione Reductase; Humans; Male; Malondialdehyde; Medicine, Traditional; Oxidative Stress; Phytotherapy; Plant Extracts; Proliferating Cell Nuclear Antigen; Prostatic Hyperplasia; Rats, Sprague-Dawley; Reactive Oxygen Species | 2018 |
Effects of different natural extracts in an experimental model of benign prostatic hyperplasia (BPH).
Topics: Ajuga; Animals; Apoptosis; Cholestenone 5 alpha-Reductase; Cyclooxygenase 2; Dihydrotestosterone; Dinoprostone; Disease Models, Animal; Epilobium; Male; Malondialdehyde; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase Type II; Phytotherapy; Plant Extracts; Prostate; Prostatic Hyperplasia; Rats, Sprague-Dawley; Selenium; Serenoa; Testosterone Propionate | 2018 |
Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats.
Topics: Animals; Antioxidants; Dihydrotestosterone; Fenofibrate; Glutathione Peroxidase; Male; Malondialdehyde; PPAR alpha; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Rats; Rats, Wistar; Superoxide Dismutase; Testosterone | 2018 |
Mangosteen pericarp components alleviate progression of prostatic hyperplasia and mitochondrial dysfunction in rats.
Topics: Animals; Body Weight; Diet, High-Fat; Dietary Supplements; Dihydrotestosterone; Disease Models, Animal; Disease Progression; Garcinia mangostana; Male; Malondialdehyde; Mitochondria; Nitric Oxide Synthase Type II; Oxidative Stress; Plant Extracts; Proliferating Cell Nuclear Antigen; Prostate; Prostatic Hyperplasia; Rats; Rats, Inbred F344; Testosterone | 2020 |
Topics: Animals; Dihydrotestosterone; DNA Methylation; Estradiol; Gastrointestinal Microbiome; Hormones; Humans; Male; Malondialdehyde; Nitric Oxide Synthase Type II; Oxidative Stress; Plant Extracts; Polysaccharides; Prostate; Prostatitis; Rats; Rats, Sprague-Dawley; Testosterone; Wolfiporia | 2020 |
Suppression of uterine and placental ferroptosis by N-acetylcysteine in a rat model of polycystic ovary syndrome.
Topics: Acetylcysteine; Animals; Antioxidants; Dihydrotestosterone; Disease Models, Animal; Female; Ferroptosis; Glutathione; Insulin Resistance; Iron; Male; Malondialdehyde; Mitochondria; Oxidative Phosphorylation; Phospholipid Hydroperoxide Glutathione Peroxidase; Placenta; Polycystic Ovary Syndrome; Pregnancy; Rats, Sprague-Dawley; Signal Transduction; Uterus | 2021 |